CIK 0001776111
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MBX Biosciences, Inc.
Sign in to watch- Ticker
- MBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 317-989-3100
- Business address
- 11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,361
- in 2 filings
Net −$288,361. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Mathers Edward T Director | Grant or award · Stock option (right to buy) | +12,500 | 12,500 | ||
| 2025-06-05 | Mathers Edward T Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2024-09-16 | Mathers Edward T Director | Conversion | +1,023,103 | 1,023,103 | ||
| 2024-09-16 | Mathers Edward T Director | Conversion | +2,091,383 | 3,114,486 | ||
| 2024-09-16 | Mathers Edward T Director | Purchase | +500,000 | $16.00 | $8.0M | 3,614,486 |
| 2024-09-16 | Mathers Edward T Director | Conversion · Series A Convertible Preferred Stock | −12,299,854 | 0 | ||
| 2024-09-16 | Mathers Edward T Director | Conversion · Series B Convertible Preferred Stock | −25,142,840 | 0 | ||
| 2024-09-12 | Mathers Edward T Director | Grant or award · Stock Option (Right to Buy) | +15,963 | 15,963 |
Page 1 of 1 · 8 trades